These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34768937)

  • 1. An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes.
    Thiemeyer H; Taher L; Schille JT; Packeiser EM; Harder LK; Hewicker-Trautwein M; Brenig B; Schütz E; Beck J; Nolte I; Murua Escobar H
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of prognosis biomarkers of prostatic cancer in a cohort of 498 patients from TCGA.
    Chen Z; Hu H
    Curr Probl Cancer; 2019 Dec; 43(6):100503. PubMed ID: 31563279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
    Fang E; Zhang X; Wang Q; Wang D
    Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel six autophagy-related genes signature for the prognostic and a miRNA-related autophagy predictor for anti-PD-1 therapy responses in prostate cancer.
    Wu L; Quan W; Yue G; Luo Q; Peng D; Pan Y; Zhang G
    BMC Cancer; 2021 Jan; 21(1):15. PubMed ID: 33402116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a candidate prognostic gene signature by transcriptome analysis of matched pre- and post-treatment prostatic biopsies from patients with advanced prostate cancer.
    Rajan P; Stockley J; Sudbery IM; Fleming JT; Hedley A; Kalna G; Sims D; Ponting CP; Heger A; Robson CN; McMenemin RM; Pedley ID; Leung HY
    BMC Cancer; 2014 Dec; 14():977. PubMed ID: 25519703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suitability of ultrasound-guided fine-needle aspiration biopsy for transcriptome sequencing of the canine prostate.
    Thiemeyer H; Taher L; Schille JT; Harder L; Hungerbuehler SO; Mischke R; Hewicker-Trautwein M; Kiełbowicz Z; Brenig B; Schütz E; Beck J; Murua Escobar H; Nolte I
    Sci Rep; 2019 Sep; 9(1):13216. PubMed ID: 31519932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of RNA‑binding motif 3 expression on the whole transcriptome of prostate cancer cells: An RNA sequencing study.
    Dong Q; Lv C; Zhang G; Yu Z; Kong C; Fu C; Zeng Y
    Oncol Rep; 2018 Oct; 40(4):2307-2315. PubMed ID: 30106430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovering Gene Signature Shared by Prostate Cancer and Neurodegenerative Diseases Based on the Bioinformatics Approach.
    Su Q; Dai B; Zhang H; Zhang S
    Comput Math Methods Med; 2022; 2022():8430485. PubMed ID: 35799671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer.
    Chen Y; Chen Z; Mo J; Pang M; Chen Z; Feng F; Xie P; Yang B
    Technol Cancer Res Treat; 2021; 20():1533033821990064. PubMed ID: 33596783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into the potential candidate genes and signaling pathways involved in lymphoma disease in dogs using a comprehensive whole blood transcriptome analysis.
    Sheet S; Oh YI; Arora D; Choi BH; Ko M; Nam Y; Lim Y; Lim JA; Park M; Park W; Seo KW; Lee KT
    Gene; 2022 Sep; 838():146735. PubMed ID: 35835403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of hub genes and evaluation of the growth regulatory role of CD44 in metastatic prostate cancer.
    Lin J; Chen Z; Li Z; Nong D; Li X; Huang G; Hao N; Liang J; Li W
    Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34296309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of tripartite motif (TRIM) family gene expression in prostate cancer bone metastases.
    Offermann A; Kang D; Watermann C; Weingart A; Hupe MC; Saraji A; Stegmann-Frehse J; Kruper R; Schüle R; Pantel K; Taubert H; Duensing S; Culig Z; Aigner A; Klapper W; Jonigk D; Philipp Kühnel M; Merseburger AS; Kirfel J; Sailer V; Perner S
    Carcinogenesis; 2021 Dec; 42(12):1475-1484. PubMed ID: 34487169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Expression Analysis Reveals Key Genes and Signalings Associated with the Prognosis of Prostate Cancer.
    Shen H; Guo YL; Li GH; Zhao W; Zhang L
    Comput Math Methods Med; 2021; 2021():9946015. PubMed ID: 34497666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis.
    Chen X; Wang J; Peng X; Liu K; Zhang C; Zeng X; Lai Y
    Medicine (Baltimore); 2020 Apr; 99(14):e19628. PubMed ID: 32243390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Potential miRNAs Biomarkers for High-Grade Prostate Cancer by Integrated Bioinformatics Analysis.
    Foj L; Filella X
    Pathol Oncol Res; 2019 Oct; 25(4):1445-1456. PubMed ID: 30367364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Identification of Key Gene Expression Signature in Prostate Cancer.
    Huang Y; Cao Q; Song Z; Ruan H; Wang K; Chen K; Zhang X
    Crit Rev Eukaryot Gene Expr; 2020; 30(2):153-168. PubMed ID: 32558494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
    Ye Y; Li SL; Wang SY
    PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
    Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
    Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics analysis identified hub genes in prostate cancer tumorigenesis and metastasis.
    Gu P; Yang D; Zhu J; Zhang M; He X
    Math Biosci Eng; 2021 Apr; 18(4):3180-3196. PubMed ID: 34198380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.